跳到正文
原文
Medical Xpress·· 39 分钟前精选AI 评分76

研究发现血压药物更可能预防心脏病和中风而非导致严重跌倒

Blood pressure medication more likely to prevent heart attacks and strokes than cause serious falls, study finds

AI 导读

一项研究量化了血压药物的益处与风险,发现这些药物在预防心脏病和中风方面比导致严重跌倒更有效,尤其对老年和虚弱患者。研究使用550万电子健康记录,表明治疗1000名患者可预防约8次严重心血管事件,导致约2次严重跌倒。

推荐理由

研究量化了血压药物的益处与风险,为医生和患者提供了个性化治疗决策的依据。

正文
blood pressure
Credit: Unsplash/CC0 Public Domain

A major study led by researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, has found that blood pressure-lowering medication is more likely to prevent serious cardiovascular events, such as heart attacks and strokes, than cause serious falls, even among older people and those living with frailty.

The study, "Benefits and harms of antihypertensive treatment a modelling study in 5.5 million electronic health records" is published in Nature Communications.

The research analyzed anonymized health records from more than 5.5 million patients in England and provides new evidence to help doctors weigh the benefits and potential harms of treatment for individual patients.

High blood pressure is a leading cause of heart disease and stroke worldwide. Although medication can substantially reduce these risks, doctors must also consider potential side effects, including dizziness, fainting, falls and kidney problems. These concerns are particularly important for older patients with frailty, who may be more vulnerable to adverse effects.

Balancing the benefits and risks of blood pressure treatment

To investigate how the benefits and risks of blood pressure treatment differ between patients, researchers developed a new cardiovascular risk calculator, called STRATIFY-CVD, using routinely collected NHS patient records. The tool estimates a person's likelihood of experiencing a serious cardiovascular event, such as a heart attack or stroke, in the next five to 10 years based on factors including their age, medical history and existing health conditions.

The researchers then combined these predictions with existing models that estimate the risk of medication-related side effects, alongside evidence from clinical trials examining the effects of blood pressure-lowering drugs. This allowed them to estimate how many heart attacks and strokes blood pressure treatment could prevent, compared with the number of adverse events it might cause, over a 10-year period.

The researchers estimated that, for every 1,000 patients treated over 10 years, blood pressure-lowering medication would prevent approximately eight serious cardiovascular events, such as heart attacks and strokes, while causing around two serious falls.

The findings also suggest that the benefits of treatment outweigh the risk of serious falls among older patients living with frailty, even though these patients are more vulnerable to medication-related falls.

For example, the researchers estimated that treating 1,000 men in their 80s with moderate frailty over 10 years would prevent 47 serious cardiovascular events, compared with nine serious falls caused by medication. By comparison, treating 1,000 fit men in their 60s with no history of cardiovascular disease was estimated to prevent 12 serious cardiovascular events while causing one serious fall.

However, the findings revealed a more complex picture for other potential side effects. For fainting and acute kidney injury, the benefits and harms of treatment were more finely balanced. For low blood pressure and elevated potassium levels (which can lead to heart palpitations and shortness of breath), the models suggested that treatment could cause more adverse events than cardiovascular events prevented, although these side effects are generally less serious than a heart attack or stroke.

James Sheppard, a professor from the Nuffield Department of Primary Care Health Sciences, University of Oxford, and senior author on the paper, said, "Deciding whether to prescribe blood pressure medication isn't always straightforward, particularly when someone is older, living with frailty or several other health conditions. Doctors need to consider not just whether a treatment works, but how much an individual patient is likely to benefit and what risks matter most to them.

"Until now, it has been difficult to bring all this information together in a simple way that informs these treatment decisions. Our research is an important step toward giving doctors and patients a clearer, more personalized picture of what treatment might mean for them.

"Ultimately, we want to help people make informed choices about their treatment, based on the best available evidence and what matters most to them."

Toward more personalized treatment options

Existing cardiovascular risk calculators are not always suitable for people who have previously experienced a heart attack or stroke, those already taking cholesterol-lowering medication, or the very oldest patients.

STRATIFY-CVD was developed to address these limitations, taking account of a person's medical history, existing health conditions and medication use. It also considers the possibility of someone dying from another cause before experiencing a heart attack or stroke.

The researchers found that the model accurately predicted cardiovascular risk when tested against an independent dataset of patient records. It generally produced lower risk estimates than the previously widely used QRISK2 calculator, suggesting that some existing approaches may overestimate cardiovascular risk.

The team also developed a chart illustrating how the estimated benefits and harms of treatment vary across different patient groups, including by age, sex, frailty and previous cardiovascular disease. This could help doctors and patients discuss treatment options and make more informed decisions.

The researchers explain that by showing that the cardiovascular benefits of blood pressure medication can outweigh the risk of serious falls, even in older patients living with frailty, the findings could help inform future treatment guidelines and support more confident, personalized prescribing decisions.

Publication details

Benefits and harms of antihypertensive treatment a modelling study in 5.5 million electronic health records, Nature Communications (2026). DOI: 10.1038/s41467-026-79283-1

Journal information: Nature Communications

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Blood pressure medication more likely to prevent heart attacks and strokes than cause serious falls, study finds (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-blood-pressure-medication-heart-falls.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com